FAMRI Center Publications

 

  1. Apollonio DE, Lopipero P, Bero L.  Participation and argument in legislative debate on statewide smoking restrictions.  Health Research and Policy System, 2007;5:12.
  2. Apollonio D, Bero L.  Evidence and argument in policymaking:  development of workplace smoking legislation.  BMC Public Health 2009;9:189, doi 10.1186/1471-2458-9-189.
  3. Aquilina NJ, Delgado-Saborit JM, Meddings C, Baker S, Harrison RM, Jacob P 3rd, Wilson M, Yu L, Duan M, Benowitz NL.  Environmental and biological monitoring of exposures to PAHs and ETS in the general population.  Environmental International 2010;36;763-771.
  4. Arjomandi M, Haight T, Redberg R, Gold WM.  Pulmonary function abnormalities in never-smoking flight attendants exposed to secondhand smoke in the aircraft cabin.  JOEM 2009; 5:639-646.
  5. Baba, A, Cook, D, McGarity, T, Bero, L.  Legislating “Sound Science”:  Role of the tobacco industry. American Journal of Public Health, 2005; S1: S20-S27.
  6. Barmes DE, Haight TJ, Mehta KM, Carlson MC, Kuller LH, Tager IB.  Secondhand smoke, vascular disease and dementia incidence:  findings from the cardiovascular health cognition study.  Am J Epidemiol 2010;171:292-302.
  7. Benowitz NL.  Cigarette smoking and cardiovascular disease:  pathophysiology and implications for treatment.  Prog Cardiovasc Dis 2003; 46: 91-111.
  8. Benowitz NL, Schultz KE, Haller CA, Wu AH, Dains KM, Jacob P 3rd.  Prevalence of smoking assessed biochemically in an urban hospital:  a rationale for routine cotinine screening.  Am J Epidemiol 2009;170:885-91.
  9. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J.  Optimal serum cotinine levels for distinguishing cigarette smokers within different racial/ethnic groups in the United States between 1999 and 2004.  Am J Epidemiol 2008;169:236-48.
  10. Benowitz NL, Dains KM, Dempsey D, Herrera B, Yu L, Jacob P III.  Urine nicotine metabolite concentrations in relation to plasma cotinine during low-level nicotine exposure.  Nicotine and Tobacco Research 2009;11:954-960.
  11. Benowitz NL.  Secondhand smoke and infectious disease in adults.  Arch Intern Med 2010;170:292-293.
  12. Benowitz NL, Dains KM, Dempsey D, Yu L, Jacob P 3rd.  Estimation of nicotine dose after low-level exposure using plasma and urine nicotine metabolites.  Cancer Epidemiol Biomarkers Prev 2010;19:1160-6.
  13. Benowitz NL.  Nicotine addiction.  N Engl J Med 2010;362;2295-303.
  14. Bernert JT, Jacob P 3rd, Holiday DV, Benowitz NL, Sosnoff CS, Doig MV, Feyerabend C, Aldous KM, Sharifi M, Kellogg MD, Langman LG.  Interlaboratory comparability of serum cotinine measurements at smoker and nonsmoker concentration levels:  a round-robin study.  Nicotine & Tobacco Research 2009;11:1458-1466.
  15. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L.  Adolescent overweight and future adult coronary artery disease.  N Engl J Med 2007;357:2371-9.
  16. Blanc PD, Eisner MD, Earnest G, Trupin L, Balmes JR, Yelin EH, Gregorich SE, Katz PP.  Further exploration of the links between occupational exposures and COPD.  J Occ Environ Med 2009;51:804-810.
  17. Bondy SJ, Zhang B, Kreiger N, Selby P, Benowitz N, Travis H, Florescu A, Greenspan NR, Ferrence R.  Impact of an indoor smoking ban on bar workers’ exposure to secondhand smoke.  J Occup Environ Med 2009; 51:612-9.
  18. Chen, H, Eisner MD, Katz PP, Yelin EH, Blanc PD.  Measuring disease-specific quality of life in obstructive airway disease:  validation of a modified version of the airways questionnaire.  Chest 2006;129:1655-1652.
  19. Choudhry S, Taub M, Mei R, Rodriguez-Santana J, Rodriguez-Cintron W, Shriver MD, Ziv E, Risch NJ, González Burchard E. Genome-wide screen for asthma in Puerto Ricans: evidence for association with 5q23 region. Human Genetics, 2008 Jun;123(5):455-68.
  20. Cook D, Bero L.  Identifying carcinogens:  The tobacco industry and regulatory politics in the United States.  Int J Health Services 2006;36:747-766.
  21. Corvol, H, De Giacomo, A, Eng, C, Seibold, M, Ziv, E, Chapela, R, Rodriguez-Santana, JR, Rodriguez-Cintron, W, Thyne, S, Watson, HG, Meade K, LeNoir, M, Avila PC, Choudhry S, González Burchard E. Genetic ancestry modifies pharmacogenetic gene-gene interaction for asthma. Pharmacogenetics and Genomics 2009;19:489-496.
  22. Drake KA, Galanter JM, González Burchard E. Race, ethnicity and social class and the complex etiologies of asthma. Pharmacogenomics; 2008;9:53-462.
  23. Eisner MD, Balmes J, Yelin E, Katz P, Hammond KS, Benowitz N, Blanc P. Directly measured secondhand smoke exposure and COPD health outcomes.  BMC Pulmonary Medicine 2006; 6:12.
  24. Eisner MD, Trupin L, Katz PP, Yelin EH, Earnest G, Balmes J, Blanc PD. Development and validation of a survey-based COPD severity score. Chest 2005; 127:1890-7.
  25. Eisner MD, Balmes J, Katz P, Trupin L, Yelin EH, Blanc PD. Lifetime environmental tobacco smoke exposure and the risk of chronic obstructive pulmonary disease. Environmental Health 2005; 4: 7.
  26. Eisner MD, Wang Y, Haight TJ, Balmes J, Hammond SK, Tager IB. Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Annals of Epidemiology 2007;17:364-73.
  27. Eisner MD.  Smoke-free legislation and acute coronary syndrome. NEJM 2008; 359;19:2070.
  28. Eisner MD. Passive smoking and adult asthma. Immunology and Allergy Clinics of North America 2008 Aug;28:521-37.
  29. Eisner MD, Jacob P 3rd, Benowitz NL, Balmes J, Blanc PD.  Longer term exposure to secondhand smoke and health outcomes in COPD:  impact of urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.  Nicotine & Tobacco Research 2009;11:945-953.
  30. Eisner MD.  Passive smoking and cognitive impairment.  BMJ 2009;338:a3070.
  31. Eisner MD, Iribarren C, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Blanc PD. Pulmonary function and the risk of functional limitation in COPD. Am J Epidemiol. 2008; 167(9):1090-101.
  32. Eisner MD, Omachi TA, Katz PP, Yelin EH, Iribarren C, Blanc PD. Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort. Chest 2009. Epub online before print December 29, 2009, doi:10.1378/chest.09-1855.
  33. Eisner MD, Blanc PD, Yelin EH, Sidney S, Katz PP, Ackerson L, Lathon P, Tolstykh I, Omachi T, Byl N, Iribarren C. COPD as a systemic disease: impact on physical functional limitations. Am J Med 2008; 121:789-96.
  34. Gan Q, Yang J, Yang G, Goniewicz M, Benowitz NL, Glantz SA.  Chinese ‘”herbal” cigarettes are as carcinogenic and addictive as regular cigarettes.  Cancer Epidemiol Biomarkers Prev 20009;18:3497-501.
  35. Goniewicz ML, Havel CM, Peng MW, Jacob P III, Dempsey D, Yu L, Zielinska-Danch W, Koxzowski B, Czogala J, Sobczak A, Benowitz NL.  Elimination kinetics of the tobacco-specific biomarker and lung carcinogen 4-(methylnitrosimino)-1-(3-pyridyl)-1-butanol.  Cancer Epidemiol Biomarkers Prev 2009:18:3421-3425.
  36. Hancock, DB, Romieu I, Shi M, Sienra-Monge JJ, Wu H, Chiu GY, Li H, del Rio-Navarro BE, Willis-Owens SAG, Weiss ST, Raby BA, Gao H, Eng C, Chapela R, Burchard EG et al.  Genome-wide association study implicates chromosome 9q.31 as a susceptibility locus for asthma in Mexican children.  PLOS Genetics 2009;5:e1000623. Epub 2009 Aug 28.
  37. Heiss C, Amabile N, Andre CL, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR, Yeghiazarians Y.  Brief secondhand smoke exposure depresses EPC activity and endothelial function:  Sustained vascular injury and blunted NO production.  J Am Coll Cardiol 2008;51:1760-1771.
  38. Hovell MF, Zakarian JM, Matt GE, Liles S, Jones JA, Hofstetter CR, Larson SN, Benowitz NL.  Counseling to reduce children’s secondhand smoke exposure and help parents quit smoking:  A controlled trial.  Nicotine and Tobacco Research 2009;11:1383-94.
  39. Jacob P III, Wilson M, Benowitz NL.  Determination of phenolic metabolites of polycyclic aromatic hydrocarbons in human urine as their pentafluorobenzyl ether derivatives using liquid chromatography-tandem mass spectrometry.  Anal Chem 2007;79:587-598.
  40. Jacob P III, Havel C, Lee DH, Yu L, Eisner MD, Benowitz NL.  Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.  Anal Chem 2008;80: 8115-21.
  41. Jewell C., Bero, L.  Public participation and claimsmaking:  Evidence utilization and divergent policy frames in California’s ergonomics rulemaking.  J Pub Admin Research and Theory.  Dec 27, 2006.  DOI:  10.1093/jpart/mul023 (this is a peer reviewed journal and the citation info is for the electronic pre-print).
  42. Jewell CJ, Bero LA.  “Developing good taste in evidence": facilitators of and hindrances to evidence-informed health policymaking in state government.  Milbank Q 2008;86:177-208.
  43. Kumar R, Seibold MA, Aldrich MC, Williams LK, Reiner AP, Colangelo L, Galanter J, Gignoux C, Hu D, Sen S, Choudhry S, Peterson EL, Rodriguez-Santana J, Rodriguez-Cintron W, Nalls MA, Leak TS, O'Meara E, Meibohm B, Kritchevsky SB, Li R, Harris TB, Nickerson DA, Doernage M, Enright P, Ziv E, Smith LJ, Liu K, Burchard EG.  Genetic ancestry in lung-function predictions.  N Engl J Med 2010 363:321-30.
  44. Lai CQ, Tucker KL, Choudhry S, Parnell LD, Mattei J, García-Bailo B, Beckman K, Burchard EG, Ordovás JM. Population admixture associated with disease prevalence in the Boston Puerto Rican health study. Hum Genet. 2008;125:199-209.  Epub 2008 Dec 24.
  45. Lazcano-Ponce E, Benowitz N, Luisa SZ, Barbosa L, Valdez R, Jacob P, Diaz R and Hernandez-Avila M.  Second hand smoke exposure in Mexican discotheques.  Nicotine and Tobacco Research, 2007;9:1021-6.
  46. Lightwood, J.  The economics of smoking and cardiovascular disease.  Prog Cardiovasc Dis 2003; 46: 39-78.
  47. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L.  Coronary heart disease attributable to passive smoking.  CHD policy model.   Am J Prev Med, 2009;36:13-20.
  48. Lopipero P, Apollonio DE, Bero L.  Interest groups, lobbying and deception:  The tobacco industry and airline smoking.  Political Science Quarterly, Winter 2007-08;12:635-656.
  49. Lopipero P, Bero L.  Tobacco interests or the public interest:  Twenty years of industry strategies to undermine airline smoking restrictions.  Tobacco Control 2006;15:323-332.
  50. Matt GE, Hovell MF, Quintana PJC, Zakarian J, Liles S, Melzer SB, Benowitz NL. The variability of urine cotinine levels in young children: Implications for measuring environmental tobacco smoke exposure. Nicotine and Tobacco Research 2007;9:83-92.
  51. Matt GE, Quintana PJE, Liles S, Hovell MF, Zakarian J, Jacob P, Benowitz NL. Evaluation of urinary trans-3’-hydroxycotinine as a biomarker of children’s environmental tobacco smoke exposure. Biomarkers 2006;11:507-23.
  52. Mathias RA, Grant AV, Rafaels N, Hand T, Gao L, Vergara C, Tsai YJ, Yang M, Campbell M, Foster C, Gao P, Togias A, Hansel NN, Diette G, Adkinson NF, Liu MC, Faruque M, Dunston GM, Watson HR, Bracken MB, Hoh J, Maul P, Maul T, Jedlicka AE, Murray T, Hetmanski JB, Ashworth R, Ongaco CM, Hetrick KN, Doheny KF, Pugh EW, Rotimi CN, Ford J, Eng C, Burchard EG, Sleiman PM, Hakonarson H, Forno E, Raby BA, Weiss ST, Scott AF, Kabesch M, Liang L, Abecasis G, Moffatt MF, Cookson WO, Ruczinski I, Beaty TH, Barnes KC. A genome-wide association study on African-ancestry populations for asthma. J Allergy Clin Immunol. 2010;125:336-346. Epub Nov 12, 2009.
  53. Max W, Sung H-Y, Shi Y.  Who is exposed to secondhand smoke?  Self-reported and serum cotinine measured exposure in the U.S. 1999-2006.  Int J Environ Res Public Health 2009; 5:1633-1648.
  54. Odierna DH, Bero LA.  Systematic reviews reveal an unrepresentative evidence base for the development of drug formularies for poor and nonwhite populations.  J of Clinical Epidemiology 2009;62:1268-78.
  55. Omachi TA, Yelin EH, Katz P, Blanc PD, Eisner MD. The COPD severity score: a dynamic prediction tool for health care utilization.  Journal of COPD 2008; 5:339-346.
  56. Eisner MD, Omachi TA, Katz PP, Yelin EH, Iribarren C, Blanc PD. Measurement of COPD severity using a survey-based score: validation in a clinically and physiologically characterized cohort. Chest 2009. October 16 (epub ahead of print)
  57. Omachi TA, Katz PP, Yelin EH, Gregorich SE, Iribarren C, Blanc PD, Eisner MD. Depression and health-related quality of life in chronic obstructive lung disease. Am J Med 2009; 122:778:e9-e15
  58. Ren X, Hsu PYF, Dulbecco FL, Fleischmann KE, Gold WM, Redberg RF, Schiller NB.  Remote second-hand tobacco exposure in flight attendants is associated with systemic but not pulmonary hypertension.  Cardiology J 2008;15:338-343.
  59. Repace J, Hughes E and Benowitz N. Exposure to secondhand smoke air pollution assessed in bar patrons' urine cotinine. Nicotine and Tobacco Research 2006;701-711.
  60. Seibold MA, Wang B, Eng C, Kumar G, Beckman KB, Sen S, Choudhry S, Meade K, Lenoir M, Watson HG, Thyne S, Williams LK, Kumar R, Weiss KB, Grammer LC, Avila PC, Schleimer RP, Burchard EG, Brenner R. An African-specific functional polymorphism in KCNMB1 shows sex-specific association with asthma severity. Hum Mol Genet. 2008 Sep 1;17(17):2681-90.
  61. Seibold MA, Donnelly S, Solon M, Innes A, Woodruff PG, Boot RG, Burchard EG, Fahy JV. Chitotriosidase is the primary active chitinase in the human lung and is modulated by genotype and smoking habit. J Allergy Clin Immunol. 2008 Nov;122(5):944-950.
  62. Sleiman M, Gundel LA, Pankow JF, Jacob P III, Singer BC, Destaillats H.  Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards.  Proc Natl Acad Sci USA 2010 Feb 8 (epub ahead of print).
  63. Stephanov I, Hecht SS, Lindgren B, Jacob P, 3rd, Wilson M, Benowitz NL.  Relationship of toenail nicotine, cotinine, and 4-(methylnitrosamino)-1-butanol to levels of these biomarkers in plasma and urine.  Cancer Epidemiol Biomarkers Prev 2007;1382-1386
  64. Tcheurekdjian, H, Thyne, SM, Williams, LK, Via, M, Rodriguez-Santana, JR, Rodriguez-Cintron, W, Avila, PC, González Burchard, E. Augmentation of bronchodilator responsiveness by leukotriene modifiers in Puerto Rican and Mexican children. Ann Allergy Asthma Immunol 2009;102:510-517.
  65. Williams LK, Oliver J., Peterson EL., Bobbitt KR., McCabe MJ, Smolarek D, Havstad SL,  Wegienka G, Burchard EG,  Ownby DR, Johnson CC.. Gene-environment interactions between CD14 C-260T and endotoxin exposure on Foxp3+ and Foxp3- CD4+ lymphocyte numbers and total serum IgE in early childhood. Ann  Allergy Asthma Immunol. 2008 Feb;100(2):128-36.
  66. Yang JJ, Burchard EG, Choudhry S, Johnson CC, Ownby DR, Favro D, Chen J, Akana M, Ha C, Kwok PY, Krajenta R, Haystad SL, Joseph CL, Seibold MA, Shriver MD, Williams LK. Differences in allergic sensitization by self-reported race and genetic ancestry. J Allergy Clinical Immunology. 2008;122:820-827.